46185LAB9

Invitae Corp

Could not find a ticker for this position, may be a filing error

A genetic testing company that analyzes DNA from saliva or blood samples to help doctors and patients understand hereditary risks — from cancer and heart conditions to neurological and pediatric disorders. It was founded in 2012 as a spin-off of the DNA sequencing firm Complete Genomics, built on the idea that genomic information should be affordable and accessible to everyone. The name 'Invitae' plays on the word 'invite,' reflecting the company's goal of welcoming people into the world of their own genetic information.

2% Convertible Senior Note due 2024

No filing summaries or text available for this security.